Heart Care Associates
Milwaukee, Wisconsin 53215
0 studies enrolling now · 5 studies all time
What they study most
Atrial Fibrillation, Pulmonary Hypertension
Studies at this site
- FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
- FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
- Safety and Efficacy of CryoCor™ Cryoablation for PAF — Completed
- ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH) — Completed
- Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension — Completed